Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)

Hong YOU; Ya-Meng SUN; Meng-Yang ZHANG; Yue-Min NAN; Xiao-Yuan XU; Tai-Sheng LI; Gui-Qiang WANG; Jin-Lin HOU; Zhongping DUAN; Lai WEI; Fu-Sheng WANG; Ji-Dong JIA; Hui ZHUANG

Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022) / 中华肝脏病杂志

Hong YOU; Ya-Meng SUN; Meng-Yang ZHANG; Yue-Min NAN; Xiao-Yuan XU; Tai-Sheng LI; Gui-Qiang WANG; Jin-Lin HOU; Zhongping DUAN; Lai WEI; Fu-Sheng WANG; Ji-Dong JIA; Hui ZHUANG.

Chinese Journal of Hepatology ; (12): 385-388, 2023.

Artigo em Chinês | WPRIM | ID: wpr-986142

ABSTRACT

ABSTRACT

Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association update the guidelines for the prevention and treatment of chronic hepatitis B (version 2022) in 2022. The latest guidelines recommend more extensive screening and more active antiviral treating for hepatitis B virus infection. This article interprets the essential updates in the guidelines to help deepen understanding and better guide the clinical practice.

Assuntos

Humanos; Hepatite B Crônica/tratamento farmacológico; Hepatite B/tratamento farmacológico; Vírus da Hepatite B; Antivirais/uso terapêutico; Gastroenterologia

Chronic hepatitis B; Guideline; Interpretation; Update

Texto completo

Imprimir

XML

Buscar no Google

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Antivirais / Vírus da Hepatite B / Hepatite B Crônica / Gastroenterologia / Hepatite B Limite: Humanos Idioma: Chinês Revista: Chinese Journal of Hepatology Ano de publicação: 2023 Tipo de documento: Artigo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

Buscar no Google